Cornelia M. Gelbmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cornelia M. Gelbmann has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
J. Schölmerich
Universität Regensburg
5 shared publications- Nicole Bregenzer
Department of Internal Medicine I, University of Regensburg, Germany
2 shared publications - T. Andus
Department of Internal Medicine I, University of Regensburg, Regensburg, Germany
2 shared publications A Hartmann
1 shared publicationA Knöll
1 shared publicationA. Schäffler
1 shared publication
Latest Publications
- 17 March 2010
- Published by Springer Nature in Die Innere Medizin
- Vol. 51 (4) , 482-488
Chronisch kranke Kinder werden erwachsen
- 17 March 2010
- Published by Springer Nature in Die Innere Medizin
- Vol. 51 (4) , 482-488
Chronisch kranke Kinder werden erwachsen
- 12 December 2007
- Published by Springer Nature in Der Gastroenterologe
- Vol. 3 (1) , 45-50
Sekundär sklerosierende Cholangitis bei Intensivpatienten
- 12 December 2007
- Published by Springer Nature in Der Gastroenterologe
- Vol. 3 (1) , 45-50
Sekundär sklerosierende Cholangitis bei Intensivpatienten
- 1 January 2006
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 114 (01) , 1-5
Lack of Correlation between the Vitamin D Receptor Fokl Start Codon Polymorphism and Bone Mineral Density in Patients with Crohn's Disease
Introduction: We have examined the association of bone mineral density of patients with inflammatory bowel disease with a polymorphism in the gene encoding the vitamin D receptor. The thymine/cytosine (T/C) polymorphism in the first of two start codons can be defined by a restriction fragment length polymorphism using the restriction endonuclease FokI. Vitamin D receptor alleles containing the polymorphism have been denoted by f and alleles lacking the site by F. Methods: We report on an association analysis of a basic population of 244 caucasian patients with Crohn's disease. We have genotyped the FokI polymorphism of the VDR in these patients and associated the genotype with the bone mineral density of the lumbar spine and the femoral neck. Results: In the cohort 42 % of the patients were scored FF homozygous, 43.7 % Ff heterozygous, and 14.3 % ff homozygous. 14.4 % of the FF patients, 18.8 % of the Ff patients, and 9.7 % of the ff patients had osteoporosis of the lumbar spine and 21.25 % of the FF patients, 25.3 % of the Ff patients, and 18.5 % of the ff patients had osteoporosis of the femoral neck. In this cohort no association between the genotype and the bone mineral density in the group as a whole nor when separated according to sex or age was found. Conclusions: In summary in our cohort no association of the FokI polymorphism and the BMD of the lumbar spine and femoral neck in patients with inflammatory bowel disease was found.
- 1 January 2006
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 114 (01) , 1-5
Lack of Correlation between the Vitamin D Receptor Fokl Start Codon Polymorphism and Bone Mineral Density in Patients with Crohn's Disease
Introduction: We have examined the association of bone mineral density of patients with inflammatory bowel disease with a polymorphism in the gene encoding the vitamin D receptor. The thymine/cytosine (T/C) polymorphism in the first of two start codons can be defined by a restriction fragment length polymorphism using the restriction endonuclease FokI. Vitamin D receptor alleles containing the polymorphism have been denoted by f and alleles lacking the site by F. Methods: We report on an association analysis of a basic population of 244 caucasian patients with Crohn's disease. We have genotyped the FokI polymorphism of the VDR in these patients and associated the genotype with the bone mineral density of the lumbar spine and the femoral neck. Results: In the cohort 42 % of the patients were scored FF homozygous, 43.7 % Ff heterozygous, and 14.3 % ff homozygous. 14.4 % of the FF patients, 18.8 % of the Ff patients, and 9.7 % of the ff patients had osteoporosis of the lumbar spine and 21.25 % of the FF patients, 25.3 % of the Ff patients, and 18.5 % of the ff patients had osteoporosis of the femoral neck. In this cohort no association between the genotype and the bone mineral density in the group as a whole nor when separated according to sex or age was found. Conclusions: In summary in our cohort no association of the FokI polymorphism and the BMD of the lumbar spine and femoral neck in patients with inflammatory bowel disease was found.
- 28 July 2004
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 36 (8) , 695-699
Use of Self-Expandable Plastic Stents For the Treatment of Esophageal Perforations and Symptomatic Anastomotic Leaks
Background and Study Aims: Extensive anastomotic leaks after esophageal resection and esophageal perforations are a therapeutic challenge. The aim of the present study was to assess the potential of the self-expandable Polyflex plastic stent for the treatment of these conditions. Patients and Methods: Between January 2002 and March 2003, nine patients were treated with a self-expandable Polyflex plastic stent for sealing of thoracic esophagoenteric anastomotic leaks following surgical resection (n = 5) or esophageal perforation (n = 4). Results: In all patients the stents were inserted successfully without technical problems. In all but two patients complete sealing of the leak was achieved as demonstrated by radiography with water-soluble contrast media. The stent migration rate was 30 % and repositioning of the migrated stents was possible in all cases. Complete mucosal healing of the esophageal leaks and stent extraction was achieved in six patients. The stents were in situ for an average period of 135 ± 78 days. Two critically ill patients with anastomotic leaks died in spite of stent insertion due to sepsis and one patient with esophageal perforation died due to the underlying malignant disease. Conclusions: Our preliminary experience with the self-expanding and removable Polyflex plastic stent for the sealing of anastomotic leaks and esophageal perforations suggests that this stent is a feasible treatment option, in particular, for more extensive esophageal defects, patients with co-morbid conditions, and critically ill patients.
- 28 July 2004
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 36 (8) , 695-699
Use of Self-Expandable Plastic Stents For the Treatment of Esophageal Perforations and Symptomatic Anastomotic Leaks
Background and Study Aims: Extensive anastomotic leaks after esophageal resection and esophageal perforations are a therapeutic challenge. The aim of the present study was to assess the potential of the self-expandable Polyflex plastic stent for the treatment of these conditions. Patients and Methods: Between January 2002 and March 2003, nine patients were treated with a self-expandable Polyflex plastic stent for sealing of thoracic esophagoenteric anastomotic leaks following surgical resection (n = 5) or esophageal perforation (n = 4). Results: In all patients the stents were inserted successfully without technical problems. In all but two patients complete sealing of the leak was achieved as demonstrated by radiography with water-soluble contrast media. The stent migration rate was 30 % and repositioning of the migrated stents was possible in all cases. Complete mucosal healing of the esophageal leaks and stent extraction was achieved in six patients. The stents were in situ for an average period of 135 ± 78 days. Two critically ill patients with anastomotic leaks died in spite of stent insertion due to sepsis and one patient with esophageal perforation died due to the underlying malignant disease. Conclusions: Our preliminary experience with the self-expanding and removable Polyflex plastic stent for the sealing of anastomotic leaks and esophageal perforations suggests that this stent is a feasible treatment option, in particular, for more extensive esophageal defects, patients with co-morbid conditions, and critically ill patients.
- 15 August 2003
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 128 (33) , 1699-1702
Diagnostische Wertigkeit der Abdominalsonografie im Primärscreening benigner Hauterkrankungen
Fragestellung:Wir untersuchten Einsatz und Nutzen der Abdominalsonographie bei der Suche nach einem abdominellen Focus für benigne Hauterkrankungen. Patienten und Methodik: Die Sonographiebefunde von 151 Patienten (mittleres Alter 56,6 Jahre; 72 Frauen und 79 Männer), die von der dermatologischen Klinik mit der Fragestellung „Focussuche” zur Abdomensonographie angemeldet worden waren, wurden retrospektiv ausgewertet. Ergebnisse: Bei diesen 151 Patienten wurden drei potenzielle Foci (zweimal Verdacht auf Leberraumforderung, einmal verdickte Darmwand) diagnostiziert. Die Leberraumforderungen konnten in der Computertomographie (CT) nicht bestätigt werden. Bei dem Patienten mit der verdickten Darmwand wurde mittels Koloskopie ein bislang unbekannter Morbus Crohn diagnostiziert. Dies entspricht einer Ausbeute von einem Focus bei 151 Sonographien (Folgerung: Die Untersuchung macht deutlich, dass die Abdominalsonographie im Primärscreening benigner Hauterkrankungen keinen Stellenwert hat. Objective: We investigated the value of abdominal ultrasound screening of abdominal foci in patients with benign diseases of the skin. Patients and methods: The data of 151 patients (age (mean) 56,6 years; male n = 79, female n = 72) from the department of dermatology were retrospectively analysed. The patients were sent for ultrasound evaluation of abdominal foci as cause of benign diseases of the skin. Results: In these 151 patients 3 potential foci were found (2 ¥ suspicion of a liver tumor, 1 ¥ thickened bowel wall). The liver tumors could not be confirmed by computed tomography, in the patient with a thickened bowel wall, a CrohnŽs disease was newly diagnosed. Abdominal ultrasound led to clinically relevant findings in fewer than 1 % of cases. We diagnosed 142 abnormal findings, mostly without clinical relevance. These abnormal findings caused follow-up examinations in 30 of the cases (19 computed tomographies; 2 magnetic resonance tomographies). Conclusion: Abdominal ultrasound does not seem useful in the primary screening of patients with benign diseases of the skin. Perhaps a more restrictive and selective use of ultrasound could be valuable.
- 15 August 2003
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 128 (33) , 1699-1702
Diagnostische Wertigkeit der Abdominalsonografie im Primärscreening benigner Hauterkrankungen
Fragestellung:Wir untersuchten Einsatz und Nutzen der Abdominalsonographie bei der Suche nach einem abdominellen Focus für benigne Hauterkrankungen. Patienten und Methodik: Die Sonographiebefunde von 151 Patienten (mittleres Alter 56,6 Jahre; 72 Frauen und 79 Männer), die von der dermatologischen Klinik mit der Fragestellung „Focussuche” zur Abdomensonographie angemeldet worden waren, wurden retrospektiv ausgewertet. Ergebnisse: Bei diesen 151 Patienten wurden drei potenzielle Foci (zweimal Verdacht auf Leberraumforderung, einmal verdickte Darmwand) diagnostiziert. Die Leberraumforderungen konnten in der Computertomographie (CT) nicht bestätigt werden. Bei dem Patienten mit der verdickten Darmwand wurde mittels Koloskopie ein bislang unbekannter Morbus Crohn diagnostiziert. Dies entspricht einer Ausbeute von einem Focus bei 151 Sonographien (Folgerung: Die Untersuchung macht deutlich, dass die Abdominalsonographie im Primärscreening benigner Hauterkrankungen keinen Stellenwert hat. Objective: We investigated the value of abdominal ultrasound screening of abdominal foci in patients with benign diseases of the skin. Patients and methods: The data of 151 patients (age (mean) 56,6 years; male n = 79, female n = 72) from the department of dermatology were retrospectively analysed. The patients were sent for ultrasound evaluation of abdominal foci as cause of benign diseases of the skin. Results: In these 151 patients 3 potential foci were found (2 ¥ suspicion of a liver tumor, 1 ¥ thickened bowel wall). The liver tumors could not be confirmed by computed tomography, in the patient with a thickened bowel wall, a CrohnŽs disease was newly diagnosed. Abdominal ultrasound led to clinically relevant findings in fewer than 1 % of cases. We diagnosed 142 abnormal findings, mostly without clinical relevance. These abnormal findings caused follow-up examinations in 30 of the cases (19 computed tomographies; 2 magnetic resonance tomographies). Conclusion: Abdominal ultrasound does not seem useful in the primary screening of patients with benign diseases of the skin. Perhaps a more restrictive and selective use of ultrasound could be valuable.
- 1 December 2001
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 13 (12) , 1431-1437
Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease
Associations between HLA-DR genotypes and susceptibility to Crohn's disease (CD) have been reported. However, it is not known whether certain HLA-DR genotypes or IL-1ra gene polymorphism are associated with responsiveness to treatment or different clinical patterns of disease. In a large, randomized, controlled multicentre trial, 318 patients with CD were treated with daily doses of 6, 9 or 18 mg budesonide. Patients were stratified into two groups: patients without steroid pretreatment and with active CD (CDAI > 150) and patients with conventional steroid pretreatment of ≤ 30 mg prednisolone per day, which was replaced by oral budesonide within 3 weeks. The HLA-DRB1 genotypes 1–16 and the IL-1ra gene polymorphism were examined for an association with budesonide treatment failure. Only HLA-DR 8 was associated with treatment failure of budesonide. HLA-DR 8 is not very common. Only 17/243 patients who could be evaluated expressed this genotype, and 13 of these 17 patients did not respond to budesonide (P < 0.00067). Neither the other HLA-DR genotypes nor the IL-1ra gene polymorphism had an influence on treatment outcome of budesonide therapy. No significant association of fistulas, perianal disease, need for bowel resections, and disease localization with certain HLA-DRB1 genotypes or the IL-1ra gene polymorphism were found. This is the first description of an association of a certain HLA-DR genotype (HLA-DR 8) with treatment failure in inflammatory bowel disease (IBD).
- 1 December 2001
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 13 (12) , 1431-1437
Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease
Associations between HLA-DR genotypes and susceptibility to Crohn's disease (CD) have been reported. However, it is not known whether certain HLA-DR genotypes or IL-1ra gene polymorphism are associated with responsiveness to treatment or different clinical patterns of disease. In a large, randomized, controlled multicentre trial, 318 patients with CD were treated with daily doses of 6, 9 or 18 mg budesonide. Patients were stratified into two groups: patients without steroid pretreatment and with active CD (CDAI > 150) and patients with conventional steroid pretreatment of ≤ 30 mg prednisolone per day, which was replaced by oral budesonide within 3 weeks. The HLA-DRB1 genotypes 1–16 and the IL-1ra gene polymorphism were examined for an association with budesonide treatment failure. Only HLA-DR 8 was associated with treatment failure of budesonide. HLA-DR 8 is not very common. Only 17/243 patients who could be evaluated expressed this genotype, and 13 of these 17 patients did not respond to budesonide (P < 0.00067). Neither the other HLA-DR genotypes nor the IL-1ra gene polymorphism had an influence on treatment outcome of budesonide therapy. No significant association of fistulas, perianal disease, need for bowel resections, and disease localization with certain HLA-DRB1 genotypes or the IL-1ra gene polymorphism were found. This is the first description of an association of a certain HLA-DR genotype (HLA-DR 8) with treatment failure in inflammatory bowel disease (IBD).
- 15 November 2000
- Vol. 95 (11)
[Liver histology in hepatitis C: correlation with different biochemical and virological parameters].
- 15 November 2000
- Vol. 95 (11)
[Liver histology in hepatitis C: correlation with different biochemical and virological parameters].
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A1038
Human intestinal mast cells produce basic fibroblast growth factor in fibrotic strictures in Crohn's disease and in normal intestine
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A1038
Human intestinal mast cells produce basic fibroblast growth factor in fibrotic strictures in Crohn's disease and in normal intestine